Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CSTL - Castle Biosciences projects $287-$297M revenue for 2025 amid strategic acquisitions and growth initiatives

CSTL - Castle Biosciences projects $287-$297M revenue for 2025 amid strategic acquisitions and growth initiatives

May, 06 2025 01:39 PM Castle Biosciences Inc.

2025-05-06 13:39:30 ET

More on Castle Biosciences

Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Call Transcript
Castle Biosciences: Steady Revenue Stream, But Medicare Reimbursement Loss A Concern
Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript
Castle Biosciences Non-GAAP EPS of -$0.20 misses by $0.13, revenue of $87.99M beats by $7.61M
Castle Biosciences Q1 2025 Earnings Preview

For further details see:

Castle Biosciences projects $287-$297M revenue for 2025 amid strategic acquisitions and growth initiatives

Stock Information

Company Name:	Castle Biosciences Inc.
Stock Symbol:	CSTL
Market:	NASDAQ
Website:	castlebiosciences.com

CSTL CSTL Quote CSTL Short CSTL News CSTL Articles CSTL Message Board

Get CSTL Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.